Assignee
JAPAN AS REPRESENTED BY DIRECTOR GENERAL OF NAT INSTITUTE OF INFECTIOUS DISEASES
JP·6 granted patents·5 pending applications·8 citations·filing 2015–2024
Top patents by PatentIndex Score
11 records- 0184US12059462B2Composition containing influenza vaccineJAPAN AS REPRESENTED BY DIRECTOR GENERAL OF NAT INSTITUTE OF INFECTIOUS DISEASES·Filed 2019·Granted Aug 13, 2024·4 cites·19 claims
- 0280US11732031B2Method for producing influenza HA split vaccineJAPAN AS REPRESENTED BY DIRECTOR GENERAL OF NAT INSTITUTE OF INFECTIOUS DISEASES·Filed 2019·Granted Aug 22, 2023·3 cites·28 claims
- 0370US2025009869A1Composition containing influenza vaccineJAPAN AS REPRESENTED BY DIRECTOR GENERAL OF NAT INSTITUTE OF INFECTIOUS DISEASES·Filed 2024·Application pending·0 cites
- 0462US10925962B2Polymeric IgA-type recombinant antibody and use thereofJAPAN AS REPRESENTED BY DIRECTOR GENERAL OF NAT INSTITUTE OF INFECTIOUS DISEASES·Filed 2015·Granted Feb 23, 2021·1 cites·13 claims
- 0561US2024299481A1Stephania cepharantha-derived alkaloid-containing preparationJAPAN AS REPRESENTED BY DIRECTOR GENERAL OF NAT INSTITUTE OF INFECTIOUS DISEASES·Filed 2024·Application pending·0 cites
- 0659US2023406910A1Method for producing influenza ha split vaccineJAPAN AS REPRESENTED BY DIRECTOR GENERAL OF NAT INSTITUTE OF INFECTIOUS DISEASES·Filed 2023·Application pending·0 cites
- 0757US2024415901A1AGENT FOR INHIBITING PROLIFERATION OF SARS-CoV-2JAPAN AS REPRESENTED BY DIRECTOR GENERAL OF NAT INSTITUTE OF INFECTIOUS DISEASES·Filed 2022·Application pending·0 cites
- 0849US12491240B2Method for producing influenza HA split vaccineJAPAN AS REPRESENTED BY DIRECTOR GENERAL OF NAT INSTITUTE OF INFECTIOUS DISEASES·Filed 2020·Granted Dec 9, 2025·0 cites·22 claims
- 0949US11299750B2Cultured transgenic cell allowing growth of norovirus, and use thereofJAPAN AS REPRESENTED BY DIRECTOR GENERAL OF NAT INSTITUTE OF INFECTIOUS DISEASES·Filed 2017·Granted Apr 12, 2022·0 cites·10 claims
- 1045US12583912B2Flavivirus cross neutralizing antibody and pharmaceutical compositionJAPAN AS REPRESENTED BY DIRECTOR GENERAL OF NAT INSTITUTE OF INFECTIOUS DISEASES·Filed 2021·Granted Mar 24, 2026·0 cites·6 claims
- 1143US2019091324A1Nasal influenza vaccine compositionJAPAN AS REPRESENTED BY DIRECTOR GENERAL OF NAT INSTITUTE OF INFECTIOUS DISEASES·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when JAPAN AS REPRESENTED BY DIRECTOR GENERAL OF NAT INSTITUTE OF INFECTIOUS DISEASES files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →